googlescholar-adv.jpg
Help ?

IGMIN: We're glad you're here. Please click "create a new query" if you are a new visitor to our website and need further information from us.

If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click "take me to my Query."

Discover the nexus of Science, Technology, Engineering, and Medicine in our Multidisciplinary Open Access Journal – a platform for breakthroughs and collaborative expertise, driving knowledge and innovation. | Important Update! Building on our inaugural year's success, adjustments to article processing charges will take effect in October. More details coming soon!
Abstract

Ji Youn Lee Editor at IgMin Research

Our mission is to foster interdisciplinary dialogue and accelerate the advancement of knowledge across a wide spectrum of scientific domains.

Biography

I got a Ph.D. degree (Radiology) at Seoul National University, which is Top of University in Korea, and got a Post Doc training in the Department of Radiology at University of Pennsylvania.  To date, my studies have focused on the development of new biomarkers for diagnosis& therapeutic approach, and evaluation their ability by in vitro and in vivo experiments related with tumor and neuroscience. These day, I’m working to learn about a new therapeutic approach using alpha and beta emitted radioisotope labeled biomarker, quality control, drug formulation and stability.

Reasearch Interest

I am an expert in the fields of molecular imaging (PET, SPECT, CT, MRI, IVIS, microscope, confocal image), CDX modelling, radio-isotope related research, set up the assay protocol (Kd, Bmax, Ki), drug screening, validation of new biomarker by in vitro assay and in vivo experiments, ADME, and analysis of data. It was provided by peer-reviewed paper publication on molecular biology, radiology, and neuroscience fields. I’m interested in the development of new biomarkers for diagnosis and therapy, the binding mechanism of biomarkers, understanding pharmacological profiles of biomarkers, and estimating possibility of therapeutic use for clinical approach. Based on expanding skills and knowledge, I would like to contribute in the field of the development of new biomarkers for diagnosis and therapy by in vitro and in vivo studies.